ArticleJournal of medicinal chemistry2012

Synthesis and characterization of a novel prostate cancer-targeted phosphatidylinositol-3-kinase inhibitor prodrug.

Daniele Baiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.